TAL
BPMC

TIG Advisors LLC’s Blueprint Medicines BPMC Stock Holding History

TIG Advisors LLC’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-305,097
Closed -$39.1M – 81
2025
Q2 		$39.1M Buy
+305,097
New +$31.7M 2.1% 17

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIG Advisors LLC's BPMC Position: Q3 2025 in Review

TIG Advisors LLC sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 305,097 shares — an estimated $39.1M sold.

TIG Advisors LLC first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $39.1M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • TIG Advisors LLC reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • TIG Advisors LLC sold 305,097 Blueprint Medicines shares in Q3 2025, an estimated $39.1M.
  • TIG Advisors LLC first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • TIG Advisors LLC's Blueprint Medicines position peaked at $39.1M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on TIG Advisors LLC's 13F filing for Q3 2025, filed 14 Nov 2025.